(Total Views: 711)
Posted On: 06/18/2020 6:50:26 AM
Post# of 153913
My apologies to the board, yes, the NASH IND has already been filed.
September 4, 2019
CytoDyn (OTCQB:CYDY) filed an IND and a Phase 2 clinical trial protocol with the FDA for the treatment of non-alcoholic steatohepatitis (NASH) with its lead drug candidate, leronlimab.....the 60-patient, randomized, double blind....
Apparently it has changed the protocol to 90 patients.
In my defense, some reference to the past of any kind (IND, change in protocol, anything) would have cleared up any readers understanding.
(0)
(0)
